New Targeted Radiopharmaceutical Therapy Achieves Remission in Pancreatic Cancer Model
A groundbreaking advancement in the field of targeted radiopharmaceutical therapy heralds a new era for treating pancreatic ductal adenocarcinoma (PDAC), ...
Tag: molecular targets in PDAC
Derazantinib Boosts Gemcitabine by Blocking MUC5AC
In a groundbreaking advance that could reshape the therapeutic landscape of pancreatic ductal adenocarcinoma (PDAC), researchers have unveiled how the ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!